多病共存纵向变化评估方法推荐:方法与应用目的相匹配
该指南性文章针对中晚年多病共存纵向研究,提出按四类研究目标(个体变化、轨迹亚组、阶段转换、与健康领域共进展)选择量化方法,并建立共同语言、指出知识空白,为研究者测量和减轻多病共存对老年人群的不良影响提供资源。
要点
- 按四类研究目标匹配多病共存纵向变化的量化方法。
- 强调建立评估多病共存纵向变化的共同语言。
- 指出多病共存进展和关键变化期的知识空白。
核心结论
- 鼓励以系统化方法定量研究多病共存变化,为测量和减轻多病共存对老龄化人群不良影响提供资源。
研究设计与样本
- 本文为方法学推荐类指南,由J Gerontol A Biol Sci Med Sci发表,识别并讨论与特定研究目标相匹配的方法。
主要发现
- 综述了多病共存测量、健康相关数据纵向分析、变化操作化等实践问题。
- 提出四类纵向研究目标:个体多病共存变化、轨迹相似亚组、向更晚期阶段转换的时机与原因、与关键健康领域的共进展。
关键数值与推荐
- 研究目标一:检查个体多病共存变化。
- 研究目标二:识别遵循相似多病共存进展轨迹的亚组。
- 研究目标三:理解个体或群体何时、如何及为何转向更晚期多病共存阶段。
- 研究目标四:检查多病共存与关键健康领域的共进展。
临床怎么用
- 老年医学科研究者可按四类研究目标选择匹配的量化方法评估多病共存纵向变化。
- 临床与研究团队可参考本文建立评估多病共存纵向变化的共同语言。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The rapidly growing field of multimorbidity research demonstrates that changes in multimorbidity in mid- and late-life have far reaching effects on important person-centered outcomes, such as health-related quality of life. However, there are few organizing frameworks and comparatively little work weighing the merits and limitations of various quantitative methods applied to the longitudinal study of multimorbidity. METHODS: We identify and discuss methods aligned to specific research objectives with the goals of (i) establishing a common language for assessing longitudinal changes in multimorbidity, (ii) illuminating gaps in our knowledge regarding multimorbidity progression and critical periods of change, and (iii) informing research to identify groups that experience different rates and divergent etiological pathways of disease progression linked to deterioration in important health-related outcomes. RESULTS: We review practical issues in the measurement of multimorbidity, longitudinal analysis of health-related data, operationalizing change over time, and discuss methods that align with 4 general typologies for research objectives in the longitudinal study of multimorbidity: (i) examine individual change in multimorbidity, (ii) identify subgroups that follow similar trajectories of multimorbidity progression, (iii) understand when, how, and why individuals or groups shift to more advanced stages of multimorbidity, and (iv) examine the coprogression of multimorbidity with key health domains. CONCLUSIONS: This work encourages a systematic approach to the quantitative study of change in multimorbidity and provides a valuable resource for researchers working to measure and minimize the deleterious effects of multimorbidity on aging populations.
引用
- Nagel CL, Bishop NJ, Botoseneanu A, et al. Recommendations on Methods for Assessing Multimorbidity Changes Over Time: Aligning the Method to the Purpose. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38742711. doi:10.1093/gerona/glae122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。